Andson Biotech GTM brain

Andson Biotech sells microfluidic sample preparation tools for mass spectrometry teams developing and characterizing biotherapeutics.

category

Mass spectrometry sample preparation

market profile

  • text: Biopharma mass spectrometry workflows can be constrained by laborious, low-throughput preparation of complex samples.
  • text: DynaChip X1 launched at ASMS 2025 and targets native mass spectrometry and biotherapeutic characterization.

personas

  • title: Mass spectrometry laboratory director
    pains:
    • Manual buffer exchange slows instrument throughput
    • Needs reliable sample preparation that works with existing MS workflows
  • title: Biotherapeutics analytical development scientist
    pains:
    • Complex protein samples require native structure preservation
    • Assay development is slowed by repetitive preparation steps
  • title: Bioprocess development leader
    pains:
    • Analytical bottlenecks delay process decisions
    • Must scale characterization as therapy programs mature

icp

  • text: Biotech and pharmaceutical companies developing biologics, cell therapies or gene therapies with in-house mass spectrometry capabilities.
  • text: Research institutions and biopharma analytical labs running native MS or protein characterization with recurring sample preparation needs.

message pillars

  • text: Simplify the sample preparation bottleneck.
  • text: Apply advanced tools to next-generation therapies.
  • text: Accelerate analytical workflows and discovery.
  • text: Build on microfluidic design for analytical work.

objections

  • objection: Will the system fit our existing instruments and assays?
    response: Request a technical evaluation of instrument compatibility, sample matrices and method performance before purchase.
  • objection: Can it preserve relevant biological structures while increasing throughput?
    response: Review application data and run representative samples against the current method.

competitors

  • name: Agilent Technologies
    website: https://www.agilent.com/en/product/automated-liquid-handling/automated-liquid-handling-applications/assaymap-bravo-protein-sample-prep-platform
    why: AssayMAP Bravo automates protein sample preparation for analytical workflows.
  • name: 908 Devices
    why: ZipChip uses microfluidics to prepare and separate samples for mass spectrometry.
  • name: Thermo Fisher Scientific
    website: https://www.thermofisher.com/us/en/home/life-science/structural-biology/optimse-workflows-for-fast-sample-screening.html
    why: OptiMSe supports automated native MS screening and online buffer exchange.

influencers

  • name: Mason Chilmonczyk
    why: Co-founder and CEO whose Georgia Tech research underpins the platform.

keywords

  • mass spectrometry sample preparation
  • native MS buffer exchange
  • automated biotherapeutic characterization
  • microfluidic sample prep
  • protein characterization mass spectrometry
  • cell therapy process analytics

voice

  • Science-forward
  • Optimistic about discovery
  • Focused on removing workflow friction

signals

  • text: A biopharma lab is scaling protein characterization and struggling with sample preparation throughput.
  • text: A team is adopting native MS or charge detection MS for biotherapeutic analysis.

stack

  • Mass spectrometry
  • Microfluidics

pricing

model: unknown

motion

sales_led

channels

  • Scientific conferences
  • application notes
  • publications
  • LinkedIn

confidence

medium

Founders

  • name: Mason Chilmonczyk
    title: Founder
    role: Founder
    bio: Mason is the co-founder and CEO of Andson Biotech, an academic spinout based on Mason's research at the Georgia Institute of Technology. At Andson, Mason is driving the company's mission to develop novel methodologies for advanced biomanufacturing discovery and monitoring. Mason is formally trained as a mechanical engineer with a BS from the University of South Florida ('14) and an MS and PhD from Georgia Tech ('17, '20).

Back to YC companies